FMT
LXRX icon

First Mercantile Trust’s Lexicon Pharmaceuticals LXRX Stock Holding History

First Mercantile Trust’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,212
Closed -$201K – 811
2017
Q2 		$201K Buy
12,212
+1,227
+11% +$19K 0.04% 565
2017
Q1 		$158K Sell
10,985
-770
-7% -$11.4K 0.02% 636
2016
Q4 		$163K Sell
11,755
-8,058
-41% -$129K 0.03% 624
2016
Q3 		$358K Buy
19,813
+9,113
+85% +$147K 0.05% 468
2016
Q2 		$154K Buy
10,700
+900
+9% +$12.2K 0.02% 654
2016
Q1 		$117K Sell
9,800
-3,600
-27% -$37.7K 0.01% 695
2015
Q4 		$178K Buy
+13,400
New +$165K 0.02% 672

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return